OpenAlex
PricingAboutJobs
Log inGet started
Work

The Efficacy and Safety of Clazakizumab, an Anti–Interleukin‐6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis

HTML

Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatology
DOI: 10.1002/art.39700
Authors: Philip J. Mease, Alice B. Gottlieb, Alberto Berman, Edit Drescher, Jun Xing, Robert Wong, Subhashis Banerjee
Institutions: University of Washington, Swedish Medical Center, Swedish Medical Center, Tufts University, Tufts Medical Center, Bristol-Myers Squibb (United States)
Language: English

Topic: Spondyloarthritis Studies and Treatments
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: clazakizumab, psoriatic arthritis, interleukin-6, monoclonal antibodies, methotrexate, ACR20 response, dose-response relationship, enthesitis, dactylitis, drug safety, musculoskeletal manifestations, skin diseases, rheumatoid factor
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2342299171
FWCI: 12.73
Cites: 28
Cited by: 163
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security